Focused multivector ultraviolet (FMUV) technology rapidly eradicates SARS-CoV-2 in-vitro: Implications for hospital disinfection of COVID-19 environments

Steven Park; David S Perlin; Sean Fitzgerald; Vidmantas Petraitis; Thomas J Walsh

doi:10.1016/j.ajic.2022.02.001

Focused multivector ultraviolet (FMUV) technology rapidly eradicates SARS-CoV-2 in-vitro: Implications for hospital disinfection of COVID-19 environments

Am J Infect Control. 2022 Jul;50(7):828-830. doi: 10.1016/j.ajic.2022.02.001. Epub 2022 Feb 11.

Authors

Steven Park¹, David S Perlin¹, Sean Fitzgerald¹, Vidmantas Petraitis², Thomas J Walsh³

Affiliations

¹ Hackensack Meridian Health Center for Discovery and Innovation, Nutley, NJ.
² Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine of Cornell University, New York, NY. Electronic address: Vip2007@med.cornell.edu.
³ Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine of Cornell University, New York, NY.

Abstract

Focused Multivector Ultraviolet technology rapidly killed the SARS-CoV-2 coronavirus in-vitro. Plates were inoculated with a mean of greater than 10⁶ plaque forming units of USA-WA1 Washington index patient strain of SARS-CoV-2 and exposed to ultraviolet, resulting in mean reductions of 99.99% within 30 seconds, 99.999% within 60 seconds, and 99.9999% within 90 seconds. These results support the effectiveness of Focused Multivector Ultraviolet technology for SARS-CoV-2 disinfection.

Keywords: Shadowless delivery; UV disinfection.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

COVID-19* / prevention & control
Disinfection / methods
Hospitals
Humans
SARS-CoV-2*
Technology
Ultraviolet Rays